Question 1

What is Stryker's P/FCF ratio?

Accepted Answer

Stryker (SYK) P/FCF ratio is 26.1× as of July 22, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month free cash flow, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/FCF ratio calculated?

Accepted Answer

P/FCF = Market Capitalisation ÷ Trailing Twelve-Month (TTM) Free Cash Flow, where Free Cash Flow = Operating Cash Flow − Capital Expenditures. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/FCF ratio?

Accepted Answer

The price-to-free-cash-flow (P/FCF) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) free cash flow. It is calculated as market cap ÷ TTM free cash flow, where free cash flow = operating cash flow − capital expenditures. Because FCF cannot be inflated by non-cash accounting items, P/FCF is often considered a cleaner measure of "earnings-power valuation" than P/E — especially for capital-intensive businesses where depreciation diverges from real cash outflows.

Question 4

What is a good P/FCF ratio for Stryker?

Accepted Answer

Mature companies that consistently convert profit into cash often trade at 15–25× P/FCF; capital-intensive businesses with lumpy capex typically trade lower. Compare against sector peers and against the company's own multi-year average — single-year P/FCF can be distorted by working-capital swings. For Stryker specifically, the relevant sector benchmark is the current sector median of 19.1×.

Question 5

Is Stryker's P/FCF ratio high or low?

Accepted Answer

Stryker's P/FCF ratio of 26.1× is below its own 5-year average of 39.1× and above the sector median of 19.1×. That places the current reading at the 2th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Stryker's historical P/FCF ratio range?

Accepted Answer

In the available daily series, Stryker (SYK) P/FCF ratio has ranged from a low of 12.2× in 2009 to a high of 104.5× in 2016. The 5-year average is 39.1× and the 5-year median is 38.7×.

Question 7

What was Stryker's P/FCF ratio in 2025?

Accepted Answer

Stryker (SYK) P/FCF ratio at the end of 2025 was 31.4×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month free cash flow figure available at that date.

Question 8

Why does Stryker's P/FCF ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (free cash flow). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$134B	$4.28B	31.4×	-8.0×	Dec 31, 2025
2024	$137B	$3.49B	39.3×	+3.1×	Dec 31, 2024
2023	$114B	$3.14B	36.3×	-9.2×	Dec 31, 2023
2022	$92.5B	$2.04B	45.5×	+8.6×	Dec 31, 2022
2021	$101B	$2.74B	36.9×	+3.8×	Dec 31, 2021
2020	$92.1B	$2.79B	33.0×	-18.0×	Dec 31, 2020
2019	$78.6B	$1.54B	51.0×	+22.2×	Dec 31, 2019
2018	$58.7B	$2.04B	28.8×	-31.5×	Dec 31, 2018
2017	$58B	$961M	60.3×	+27.0×	Dec 31, 2017
2016	$44.9B	$1.35B	33.3×	-22.0×	Dec 31, 2016
2015	$34.8B	$629M	55.3×	+32.3×	Dec 31, 2015
2014	$35.7B	$1.55B	23.0×	+6.2×	Dec 31, 2014
2013	$28.4B	$1.69B	16.8×	+2.4×	Dec 31, 2013
2012	$20.8B	$1.45B	14.4×	-1.3×	Dec 31, 2012
2011	$18.9B	$1.21B	15.7×	+0.3×	Dec 31, 2011
2010	$20.9B	$1.37B	15.3×	+0.3×	Dec 31, 2010
2009	$20B	$1.33B	15.0×	-0.5×	Dec 31, 2009
2008	$15.8B	$1.02B	15.5×	-21.0×	Dec 31, 2008
2007	$30.7B	$841M	36.6×	+1.9×	Dec 31, 2007
2006	$22.5B	$650M	34.7×	+4.2×	Dec 31, 2006
2005	$18B	$592M	30.4×	-17.5×	Dec 31, 2005
2004	$19.4B	$406M	47.9×	+14.2×	Dec 31, 2004
2003	$17B	$504M	33.7×	-2.8×	Dec 31, 2003
2002	$13.3B	$365M	36.5×	—	Dec 31, 2002


McKesson (MCK)	17.8×
Gilead Sciences (GILD)	16.9×
DexCom (DXCM)	16.9×
Pfizer (PFE)	16.7×
Humana (HUM)	16.4×
Quest Diagnostics (DGX)	16.3×
UnitedHealth Group (UNH)	15.9×
Labcorp Holdings (LH)	15.9×
Becton, Dickinson and (BDX)	14.0×
HCA Healthcare (HCA)	13.5×
Elevance Health (ELV)	13.4×
Incyte (INCY)	12.9×
CVS Health (CVS)	12.4×
Universal Health Services (UHS)	12.2×
Baxter International (BAX)	12.1×
Cardinal Health (CAH)	11.3×
IQVIA (IQV)	11.3×
Bristol-Myers Squibb (BMY)	10.4×
Biogen (BIIB)	10.3×
Zimmer Biomet Holdings (ZBH)	9.6×
Cigna (CI)	9.1×
Viatris (VTRS)	9.1×
DaVita (DVA)	6.9×
Teladoc Health (TDOC)	3.9×
Centene (CNC)	2.5×

P/FCF Ratio for Stryker (SYK) 2002-2026

P/FCF Ratio daily chart for Stryker (SYK)

Historical P/FCF Ratio for Stryker (SYK) from 2002 to 2025

About P/FCF Ratio at Stryker (SYK)

Stryker P/FCF Ratio by Year

Stryker P/FCF Ratio 2025: 31.4×

Stryker P/FCF Ratio 2024: 39.3×

Stryker P/FCF Ratio 2023: 36.3×

Stryker P/FCF Ratio 2022: 45.5×

Stryker P/FCF Ratio 2021: 36.9×

Sector peers by P/FCF Ratio — chart

Sector peers by P/FCF Ratio — table

Frequently asked questions

Stryker (SYK) Key Financials